ARDMORE, OK -- While it may seem like the worst part of the H1N1 flu outbreak has passed, Carter County health officials tell us there is still a need to get vaccinated.
The health department held a drive-through H1N1 clinic Monday to make it quick and easy for residents get the shot.
The health department says they have already reached all of the high-risk groups, so now the vaccine is available for everyone on a first-come, first-serve basis.
The clinic gave over 500 doses Monday, and say it's still important for the community to be aware of H1N1.
"Usually the flu actually peaks in January and February, so were not really for sure if it's going to peak more in January and February or if this is where we are going to see it. But we encourage everyone to come and get vaccinated, "Carter County nurse Kristi Insleman says.
The health department says they will be given the H1N1 shots to residents at the Carter County Health Department office for the rest of the week as long as they last.
They showed fewer signs of emotional problems if they weren't cared for solely by their mother
And that can pose serious psychological challenges, researcher says
Eating a healthy diet is good for anyone, and it's key if you have HIV. Find out what to put on your plate.
More people with HIV are living longer than in the past. Read how HIV affects aging and how to plan for getting older if you have HIV.
Common signs of type 1 diabetes often resemble symptoms of other illnesses
LONDON (AP) — A mysterious new respiratory virus that originated in the Middle East spreads easily between people and appears more deadly than SARS, doctors reported Wednesday after investigating the biggest outbreak in Saudi Arabia.
SINGAPORE (AP) — Singapore urged people to remain indoors amid unprecedented levels of air pollution Thursday as a smoky haze wrought by forest fires in neighboring Indonesia worsened dramatically. Nearby Malaysia closed 200 schools and banned open burning in some areas.
LONDON (Reuters) - GlaxoSmithKline is investing 17.5 million euros ($23.5 million) in a new venture fund to invest in drugs for rare diseases, underscoring the growing role of big drugmakers in backing start-up companies. GSK and many of its rivals are becoming more active in funding early-stage companies, reflecting both a desire to tap into smart ideas from outside their own laboratories and a scarcity of finance from many traditional venture capital firms. ...
